CD14 and metabolic dysfunction-associated steatohepatitis: The expression of hsa-miR146b-5p in CD3+ T cells and CD14+ monocytes of the CH-C patients was significantly lower than in the other groups (CH-B patients, NASH patients and healthy subjects) (Fig. 3B)(p < 0.05).